Colibri Heart Valve Initiates International CE Mark-enabling Pilot Study of Second-Generation TAVI System
03 nov. 2021 11h52 HE
|
Colibri Heart Valve LLC
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the...
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
24 sept. 2019 16h01 HE
|
Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
14 mai 2019 10h00 HE
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve to Present Patient Follow-up Results from Clinical Feasibility Study of Second-Generation TAVI System at TCT
19 sept. 2018 14h12 HE
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
04 mai 2018 11h09 HE
|
Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
19 mars 2018 10h52 HE
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been successfully...
Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification
03 mars 2017 10h00 HE
|
Colibri Heart Valve, LLC
BROOMFIELD, CO , March 03, 2017 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announced today that it has...
Colibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve Technologies
13 sept. 2016 08h00 HE
|
Colibri Heart Valve, LLC
Broomfield, CO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has entered into definitive...
Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter
27 avr. 2016 08h00 HE
|
Colibri Heart Valve LLC
BROOMFIELD, CO , April 27, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that patent...
Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart
25 févr. 2016 15h00 HE
|
Colibri Heart Valve LLC
BROOMFIELD, CO , Feb. 25, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announces the formation of a...